Clinical trial
An Open-label Extension of BPS-314d-MR-PAH-302 in Pulmonary Arterial Hypertension Patients
NCT03657095 is registered in ClinicalTrials.gov with Lung Biotechnology PBC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Extension of BPS-314d-MR-PAH-302 in Pulmonary Arterial Hypertension Patients
- Lead sponsor
- Lung Biotechnology PBC
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 10, 2018
- Completion date
- July 20, 2019
- Enrollment
- 112 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.